Earnings call briefThird-quarter 2026

Vistra says line of sight to approximately 70% per-share cash flow growth, 2027 to 2030

Vistra said it has line of sight to approximately 70% growth in adjusted free cash flow before growth per share from 2027 to 2030, on current forward curves and assumed buybacks.

GetSignal Vistra VST

Executive Vice President and Chief Financial Officer Kristopher Moldovan said on the third-quarter call that Vistra has line of sight to approximately 70% growth in adjusted free cash flow before growth per share from 2027 to 2030, using current forward curves and a simplifying assumption that excess cash goes to share repurchases. Vistra said it believes it would achieve leverage metrics meaningfully below the level needed for BBB flat and Baa2 over 2027 to 2030 under the same assumptions.

Quotes from the call

“We have line of sight to approximately 70% growth in adjusted free cash flow before growth per share from 2027 to 2030, while achieving leverage metrics meaningfully below what we believe would be required for us to be at our target ratings of BBB flat and Baa2.”

Kristopher Moldovan, Executive Vice President and Chief Financial Officer

Key facts from the call

Expected 2027 to 2030 adjusted free cash flow before growth per share growth
approximately 70%, which the company said it has line of sight to using current forward curves and a simplifying assumption on share repurchases, with leverage metrics meaningfully below BBB flat and Baa2 levels
Expected use of share repurchase authorization
approximately $2.5 billion of authorization, which the company currently expects to fully utilize by no later than the end of 2028
Target return threshold for investment decisions
mid-teens or higher on a levered basis

All VST call briefs

Source: Vistra's third-quarter 2026 earnings call, November 6, 2026.

Written by GetSignal with AI from the company's earnings call.

Not investment advice.

More earnings call briefs

  1. Constellation Energy expects nuclear uprate costs of about $4.3 billion

    CEG  Constellation Energy  Q3 2026 call 

  2. Brookfield Asset Management now sees 2026 earnings modestly below early view

    BAM  Brookfield Asset Management  Q3 2026 call 

  3. 10x Genomics raises 2026 revenue outlook to $625 million to $635 million

    TXG  10x Genomics  Q3 2026 call 

All earnings call briefs

Follow Vistra on GetSignal

Its earnings call briefs, filings, insider trades and company news in one feed. Free on iPhone and Android.

Download on the App Store Get it on Google Play